NOX3 and hearing loss disorder: The exclusive and specific expression of NOX3 in the inner ear opens interesting opportunities for pharmacological (Augsburger et al., 2019) or molecular (Rousset et al., 2019) interventions aiming at prevention of several acquired forms of hearing loss including noise-induced hearing loss.